Biotin Safety, Side Effects and Contraindications: An Evidence-Based Guide

Biotin sits in millions of medicine cabinets, usually sold for hair, skin and nails. Most people who take it never notice a problem. Yet in 2017 the US Food and Drug Administration (FDA) warned that supplemental biotin can distort common blood tests, and a patient death was later linked to a missed heart-attack diagnosis. Understanding biotin safety means holding two facts at once: the vitamin is well tolerated by most healthy people, and a few specific risks deserve real attention.

This guide reviews what human evidence actually shows about biotin: which adverse effects are established, which are rare reports, and which remain theoretical. It is educational and does not replace advice from your doctor or pharmacist. Read on to learn what is known, what is not, and how to decide whether a conversation with a clinician is warranted before your next dose.

Last reviewed: October 2026. Sources are listed at the end; confirm current guidance with your healthcare professional.

Biotin Safety Summary: What the Evidence Says

Biotin (vitamin B7, also called vitamin H) is a water-soluble B vitamin that acts as a coenzyme for carboxylase enzymes involved in fatty acid synthesis, gluconeogenesis and amino acid breakdown. Because it is water-soluble, excess amounts are largely excreted in urine rather than stored.

Key points at a glance:

• Dietary intake is safe. The US National Institutes of Health Office of Dietary Supplements (NIH ODS) sets an Adequate Intake of 30 micrograms (mcg) per day for adults, 30 mcg in pregnancy and 35 mcg during lactation. These are not upper limits.
• No Tolerable Upper Intake Level (UL) has been set. The NIH ODS notes that no adverse effects from high biotin intake have been firmly established, which reflects limited data as much as proof of harmlessness.
• The best-documented risk is laboratory interference, not toxicity. Biotin can cause falsely high or falsely low results on certain immunoassays, with potentially serious clinical consequences.
• Allergic-type reactions, skin reactions and digestive upset are reported only occasionally and are mostly based on case reports.
• Safety data at supplement doses are mainly short-term. Long-term trials in healthy people are scarce.

If you take any biotin supplement and expect a blood test, tell the clinician and the laboratory. That single step addresses the most evidence-backed safety concern.

Biotin Side Effects: Common Reported Adverse Effects

In randomized trials and observational reports, biotin at typical supplement doses (roughly 2.5 to 10 mg per day, often sold as 5,000 to 10,000 mcg) has generally been well tolerated. When adverse events are reported, they tend to be mild and non-specific and are not consistently more frequent than with placebo.

Reported effects include:

• Gastrointestinal symptoms: nausea, cramping or loose stools. These appear sporadically and are not clearly attributable to biotin in controlled studies.
• Skin changes: some people report acne-like eruptions or breakouts after starting high-dose biotin. A proposed mechanism is competition with pantothenic acid (vitamin B5) for the same intestinal transporter, but this has been demonstrated mainly in laboratory and animal work. Human confirmation is lacking, so this should be treated as unconfirmed.
• Headache, fatigue or sleep disturbance: mentioned in consumer reports and occasional trial listings, without a consistent signal.
• Increased urination or thirst: occasionally reported anecdotally; no established mechanism or dose-response data.

The honest takeaway is that common biotin side effects are mild, infrequent and often indistinguishable from background symptoms. Most of what circulates online comes from self-reports, which cannot prove cause and effect.

Less Common and Serious Reports

Serious events are rare, but the literature contains several categories worth knowing about.

Misleading laboratory results leading to harm

This is the most important category (detailed below). The FDA has received reports of adverse events linked to biotin interference, including one death in a person taking high-dose biotin whose troponin result appeared falsely low.

Hypersensitivity

Case reports describe rashes, hives or other allergic-type reactions in people taking biotin-containing products. Because supplements contain fillers, dyes, gelatin and other additives, the reaction is not always caused by biotin itself.

Eosinophilic pleural effusion and other isolated case reports

A small number of published case reports have linked biotin-containing supplements to unusual inflammatory or eosinophilic reactions. Such reports are hypothesis-generating only; they show temporal association, not proven causation.

Reports from high-dose multiple sclerosis trials

In trials of pharmaceutical-grade high-dose biotin (300 mg per day, which is about 10,000 times the Adequate Intake), the main safety observations were laboratory abnormalities from assay interference. In one phase 3 trial, people receiving biotin more often showed thyroid test patterns that looked abnormal, and these were attributed to interference rather than real thyroid disease. These doses are used only in supervised research and should never be extrapolated to over-the-counter use.

Theoretical or unconfirmed concerns

The following are discussed in the literature but lack robust human evidence:

• Competition with vitamin B5 absorption at high doses.
• Effects on fetal development at very high doses (no controlled human data).
• Altered biotin-dependent enzyme activity or changes in lipid and glucose metabolism with long-term mega-dosing.

It is useful to separate three tiers: established (laboratory interference), reported but unproven (hypersensitivity, acne-like rashes, isolated case reports), and theoretical (nutrient competition, developmental effects).

Biotin Lab Test Interference: Thyroid, Troponin and Beyond

This section covers the best-documented clinical hazard of supplemental biotin.

Why interference happens

Many automated immunoassays use a biotin-streptavidin binding step to capture the molecule being measured. Excess biotin in the blood competes with the biotin-labelled reagents, which disrupts the test. How the result is distorted depends on assay design:

• Sandwich (non-competitive) assays tend to give falsely low results. Examples include cardiac troponin, thyroid-stimulating hormone (TSH), parathyroid hormone, ferritin and some tumour markers.
• Competitive assays tend to give falsely high results. Examples include free thyroxine (FT4), free and total triiodothyronine (T3), total T4, and some assays for vitamin D, cortisol and certain sex hormones.

The interference is assay-specific. Different manufacturers use different formats, so the same patient could show distortion on one platform and not another.

Thyroid tests

In a controlled study published in JAMA in 2017, healthy adults taking 10 mg of biotin daily for one week showed marked changes in several hormone assays, including patterns that look like hyperthyroidism (low TSH with high free thyroid hormones). Case reports describe people being investigated or even treated for Graves disease before biotin was identified as the cause. Stopping biotin and retesting resolved the pattern in these reports.

Cardiac troponin

Troponin is the key marker for diagnosing heart attack. Many troponin assays are sandwich-type, so biotin can push a genuinely elevated value down, potentially masking myocardial injury. The FDA's safety communications (issued in 2017 and updated in 2019) highlighted this risk, stated that it had received a report of a death, and asked laboratories and manufacturers to communicate interference limits. Not all troponin platforms are affected, and some manufacturers have reformulated assays to tolerate higher biotin levels, but patients usually cannot know which method a given hospital uses.

Other affected tests

Published reviews list potential effects on assays for hCG (including pregnancy tests performed in a laboratory), PSA, digoxin, vitamin B12, folate, anti-nuclear and other antibody tests, and various hormones. Over-the-counter home tests may also be affected depending on their design.

Practical steps (general information, not individual advice)

• Tell every clinician and laboratory that you take biotin, including doses in multivitamins and hair products.
• Many laboratories and clinical guidelines suggest pausing biotin before blood draws. A commonly cited window is at least 48 to 72 hours for supplements up to about 10 mg per day. Much higher doses or impaired kidney function may call for longer, so follow your clinician's or laboratory's instructions.
• In an emergency, such as chest pain, always report biotin use, but do not delay care on the assumption that tests alone will rule out a problem.
• If results do not fit your clinical picture, ask whether biotin interference could be responsible and whether the test can be repeated or run on a different platform.

Biotin Dosage and Dose-Related Safety

Biotin dosage matters mainly because of laboratory interference, which rises with the amount taken.

Context	Typical amount	Safety notes
Adequate Intake (adults)	30 mcg/day	Meets needs of most healthy adults; food sources suffice
Standard multivitamin	30 to 300 mcg	Low interference risk, though not zero for sensitive assays
Hair, skin and nail products	2,500 to 10,000 mcg (2.5 to 10 mg)	Documented to interfere with several assays
Research and medical use	Up to 300 mg/day	Supervised only; strong interference expected

What the evidence shows:

• No UL exists. Authoritative bodies, including the NIH ODS and earlier expert panels, did not find enough data to set a safe upper limit. This absence does not mean unlimited doses are proven safe.
• Pharmacokinetic reality. Supplements of 5 to 10 mg raise blood levels by hundreds or thousands of times compared with dietary intake. Interference in tests is detectable for many hours after a single dose.
• Dietary intake is far lower. Foods such as eggs, organ meats, fish, seeds, nuts and some vegetables supply a few to tens of micrograms; deficiency is uncommon in healthy people eating varied diets.
• Marketing doses exceed need. Most products supply hundreds of times the Adequate Intake. Whether this offers any benefit for people without deficiency is unproven.

This article does not recommend a specific dose for any individual. Appropriate use depends on diagnosis, health status and medications, and should be decided with a healthcare professional.

Duration of Use in Clinical Trials

Human studies give limited insight into how long supplemental biotin has been tested:

• Hair and nail studies have typically been short, often a few weeks to several months, and many are small, uncontrolled or involve people with suspected deficiency or brittle nails.
• Multiple sclerosis trials of high-dose biotin lasted about 12 to 24 months for some endpoints, with extension phases. These are the longest controlled data, but they used pharmaceutical-grade doses in a specific patient population, with mixed efficacy results and no clear evidence of serious toxicity beyond interference.
• Diabetes and lipid studies testing biotin with chromium or alone have been small and short.
• Biotinidase deficiency and inborn errors are managed with lifelong biotin under specialist care, and long-term experience in these groups suggests good tolerance, but these patients have unique physiology.

In short, there is reasonable short-term tolerability data, some medium-term data at very high doses in a patient population, and almost no multi-year trials in healthy supplement users.

Biotin Contraindications and Precautions

Formal biotin contraindications are few. Instead, the evidence supports a set of precautions.

Absolute or near-absolute situations

• Known hypersensitivity to biotin or to any ingredient in a specific product is a reason not to use that product.

Situations calling for caution or medical guidance

• Upcoming blood tests, especially thyroid function, troponin, hormone or tumour-marker testing, or pregnancy testing in a laboratory.
• Suspected or known heart disease or symptoms of acute coronary syndrome, given the troponin risk.
• Thyroid disease, because false results could lead to wrong diagnosis or dose changes of thyroid medication.
• Pregnancy and breastfeeding: adequate intake is recommended, but high-dose supplements lack controlled safety data. Discuss with an obstetric provider. Note that some prenatal vitamins already contain biotin.
• Children: supplementation beyond what a doctor recommends is not advised. Interference has been described in pediatric testing as well.
• Kidney impairment: biotin is eliminated mainly by the kidneys, so levels may stay higher for longer, prolonging assay interference; evidence is limited.
• Medications that may interact: anticonvulsants such as carbamazepine, phenytoin and primidone, and long-term alcohol use, may lower biotin levels; this is a reason for clinician review rather than a reason for self-treatment.
• Raw egg white consumption: the protein avidin binds biotin and can induce deficiency when eaten in large raw quantities. This is the opposite problem, but relevant to dietary advice.

These precautions come from regulatory warnings, laboratory medicine reviews and case reports. They are not a complete list of reasons to avoid biotin, and your own circumstances may differ.

Allergy Considerations

True biotin allergy appears rare. Many reactions attributed to biotin may come from other ingredients in the formulation, including:

• Gelatin, soy, gluten, milk-derived or other excipients
• Artificial dyes and flavours
• Botanical extracts in combination hair-and-nail blends

If you have previous allergic reactions to supplements, check the full ingredient list and consider products with minimal additives. A reaction involving hives, swelling or breathing difficulty requires emergency care (see below). An allergist can help distinguish a biotin reaction from an excipient reaction.

Organ-Specific Concerns Where Documented

• Heart: the documented concern is diagnostic, not toxic. Biotin has not been shown to damage the heart, but interference with troponin can delay diagnosis of a heart attack.
• Thyroid: biotin does not appear to harm the thyroid gland. The issue is misleading thyroid test results that can lead to unnecessary tests, wrong diagnoses or inappropriate medication changes.
• Skin: acne-like eruptions have been reported, but causal evidence in humans is limited.
• Liver: no consistent evidence of hepatotoxicity at supplement doses has been published, although data are sparse. Biotin is not listed among the supplements with established liver injury risk.
• Kidney: no known direct kidney toxicity. Reduced kidney function can prolong blood levels (see above).
• Reproductive health and pregnancy: high-dose effects are unstudied in controlled trials. Marginal biotin deficiency has been described in pregnancy, but this does not justify high-dose supplementation.
• Eyes and nervous system: multiple sclerosis trials did not identify a pattern of neurotoxicity, though trial sizes and populations were limited.

When to Stop Biotin and Seek Care

Stop taking the supplement and contact a clinician, or seek urgent care where indicated, in these situations:

Seek emergency care immediately if you have:

• Hives, facial or throat swelling, wheezing or trouble breathing
• Chest pain, pressure, shortness of breath, or other symptoms of a possible heart attack. Tell the care team you take biotin

Contact a healthcare professional promptly if:

• You develop a new rash, persistent acne-like eruption or intense itching
• You have persistent vomiting, severe abdominal pain or other symptoms that began after starting the product
• You have been told your thyroid or hormone test results are unexpected, especially if you do not have symptoms
• You are scheduled for blood tests, surgery or a hospital procedure
• You are pregnant, planning pregnancy or breastfeeding and taking more than the amount in a standard prenatal vitamin
• You take prescription medications and want to start high-dose biotin

When stopping, you generally do not need to taper biotin. Ask your pharmacist whether any other products you use also contain it, since biotin appears in multivitamins, B-complex tablets, gummies, protein powders and some shampoos and serums.

If you notice a health concern that may be related to a supplement, you can report it through your national system, such as the FDA's MedWatch program in the United States.

Safety Evidence Quality

How strong is the evidence? A fair assessment looks like this:

Safety topic	Evidence strength	Comment
Laboratory test interference	Strong	Regulatory warnings, controlled studies, many case reports
General tolerability at 2.5 to 10 mg for weeks to months	Moderate-low	Small trials, mixed quality, limited reporting of adverse events
High-dose (300 mg) tolerability in MS	Moderate	Randomized trials, but narrow population and some conflicting efficacy
Hypersensitivity, rashes	Low	Case reports and self-report
Pregnancy and child safety at high dose	Very low	Essentially absent controlled data
Nutrient competition (B5)	Very low	Mostly preclinical

Common limitations include small samples, short follow-up, inconsistent adverse event reporting, supplement product variability (actual content sometimes differs from labels), and many studies funded by or conducted in conditions where biotin was a treatment rather than an elective supplement.

Long-Term Safety Gaps

Several questions remain unanswered:

1. Years-long use in healthy adults. Few if any controlled studies track people taking 5 to 10 mg daily for years.
2. Pregnancy, lactation and childhood. High-dose effects are not adequately studied.
3. Interaction with chronic disease. Whether kidney, liver or metabolic disease changes safety is unclear.
4. Real-world incidence of lab-related harm. Case reports and regulatory notices exist, but the true frequency of misdiagnosis is unknown, partly because interference is underrecognized.
5. Assay evolution. Manufacturers are developing biotin-resistant assays, so risk may shift over time, but adoption differs by region and laboratory.
6. Product quality. Supplements are not approved by regulators before sale in many countries, so independent testing seals (for example from third-party programs) may help verify content, though they do not prove safety or effectiveness.

Because of these gaps, the statement that biotin has no known toxicity is more accurately phrased as no firmly established toxicity at studied doses, within the limits of the available data.

Frequently Asked Questions

Is biotin safe to take every day?

For most healthy adults, intakes at or near the Adequate Intake (30 mcg) from food and standard multivitamins are considered safe. Higher-dose daily supplements are commonly used and generally well tolerated in short-term studies, but long-term data are limited and laboratory interference is a real concern. Discuss ongoing use with your healthcare provider.

Can biotin cause thyroid problems?

There is no good evidence that biotin harms the thyroid itself. It can, however, make thyroid blood tests look abnormal, which may mimic hyperthyroidism on some assays. Telling your doctor about biotin and repeating the test after stopping is the standard approach.

How long before a blood test should I stop biotin?

Many laboratories suggest at least 48 to 72 hours for supplements up to about 10 mg per day, and longer for much higher doses. Because recommendations vary by assay and kidney function, ask the laboratory or your clinician.

Does biotin cause acne?

Some people report breakouts, and a link with vitamin B5 competition has been proposed. Human evidence is limited and inconsistent, so the connection remains unconfirmed.

Can I take biotin during pregnancy?

Pregnancy increases biotin requirements slightly (Adequate Intake 30 mcg). Most prenatal vitamins already contain biotin. High-dose stand-alone supplements have not been well studied, so check with your obstetric provider.

Does biotin interact with medications?

No major drug interactions are firmly established, but some anticonvulsants and long-term alcohol use may reduce biotin status. The most common practical interaction is with laboratory tests rather than with other medicines.

What is the maximum safe dose of biotin?

No official upper limit has been set because evidence is insufficient. That does not guarantee safety at any dose; it reflects uncertainty.

Is a biotin overdose dangerous?

Acute toxicity has not been described at supplement doses, and excess is mostly excreted. The main hazard of excessive intake is misleading test results.

Final Thoughts and Next Step

Biotin is neither a hazardous supplement nor a risk-free one. For most healthy adults, food-level intake is safe, and short-term supplement use is usually well tolerated. The consistent, evidence-based warning is about laboratory interference that can delay a heart-attack diagnosis or suggest a thyroid disorder that is not there. If you use biotin, review the label, list it on every medical form, and ask your clinician before your next blood draw whether to pause it. Take that one step today: check your supplements and share the list with your doctor or pharmacist.

Medical disclaimer: This article is for general education and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider about your own situation.

References

1. National Institutes of Health, Office of Dietary Supplements. Biotin: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Biotin-HealthProfessional/
2. US Food and Drug Administration. Update: The FDA Warns that Biotin May Interfere with Lab Tests: FDA Safety Communication (2019). https://www.fda.gov/medical-devices/safety-communications/update-fda-warns-biotin-may-interfere-lab-tests-fda-safety-communication
3. Li D, Radulescu A, Shrestha RT, et al. Association of biotin ingestion with performance of hormone and nonhormone assays in healthy adults. JAMA. 2017;318(12):1150-1160. doi:10.1001/jama.2017.13705. PubMed: https://pubmed.ncbi.nlm.nih.gov/28973291/
4. Samarasinghe S, Meah F, Singh V, et al. Biotin interference with routine clinical immunoassays: understand the causes and mitigate the risks. Endocrine Practice. 2017;23(8):989-998. PubMed: https://pubmed.ncbi.nlm.nih.gov/28474966/
5. Patel DP, Swink SM, Castelo-Soccio L. A review of the use of biotin for hair loss. Skin Appendage Disorders. 2017;3(3):166-169. doi:10.1159/000462981
6. Soleymani T, Lo Sicco K, Shapiro J. The infatuation with biotin supplementation: is there truth behind its rising popularity? Journal of Clinical and Aesthetic Dermatology. 2017;10(9):28-39. PubMed: https://pubmed.ncbi.nlm.nih.gov/29344319/
7. Tourbah A, Lebrun-Frenay C, Edan G, et al. MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: a randomised, double-blind, placebo-controlled study. Multiple Sclerosis Journal. 2016;22(13):1719-1731. doi:10.1177/1352458516667568
8. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. National Academies Press; 1998. https://www.ncbi.nlm.nih.gov/books/NBK114310/
9. US FDA. MedWatch: The FDA Safety Information and Adverse Event Reporting Program. https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program

Reference note: verify each link and DOI against the original source before publication, and have a qualified clinician or pharmacist review the content.